What are small molecules?
The small molecule market, which accounts for two-thirds of the global pharmaceutical market, is worth approximately 1,460 billion USD. Celltrion is successfully conducting various global chemical projects to become a key leader of the global pharmaceutical market.
Business Strategy
Targeting Global Pharmaceutical Market with Step-by-step Growth Strategy
Starting with Temixys, the first HIV IMD to be approved by the US FDA, Celltrion takes the lead in the global generic pharmaceutical
market by entering the US and global tender markets and building its global distribution network.
-
01Secure Presence in the Global Market
Open details- Develop IMDs and generic drugs
- Enter the US and global tender markets
- Perform initial clinical trials for new drugs
-
02Acquire New Portfolios and Boost Global Sales
Open details- Carry out global clinical trials for new drugs
- Secure 20 or more generic products in portfolio
- Expand global direct sales network
-
03Become a Global Pharmaceutical Company
Open details- Globally launch new drugs
- Build a stable sales structure
- Take the lead in the global generic pharmaceutical market